Phibro Animal Health Corporation
PAHC
$24.60
$0.100.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.19B | 1.11B | 1.05B | 1.02B | 999.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.19B | 1.11B | 1.05B | 1.02B | 999.56M |
| Cost of Revenue | 806.46M | 752.12M | 717.38M | 704.07M | 696.44M |
| Gross Profit | 384.23M | 353.96M | 329.38M | 313.61M | 303.13M |
| SG&A Expenses | 228.97M | 217.95M | 207.88M | 213.96M | 212.06M |
| Depreciation & Amortization | 2.99M | 2.99M | 2.99M | 2.99M | 3.05M |
| Other Operating Expenses | 4.20M | 4.20M | 4.20M | 4.20M | 0.00 |
| Total Operating Expenses | 1.07B | 1.01B | 961.64M | 954.41M | 935.94M |
| Operating Income | 118.87M | 99.63M | 85.12M | 63.27M | 63.63M |
| Income Before Tax | 50.55M | 33.79M | 32.52M | 10.92M | 25.95M |
| Income Tax Expenses | 18.76M | 14.47M | 15.11M | 8.50M | 12.79M |
| Earnings from Continuing Operations | 31.79 | 19.32 | 17.41 | 2.42 | 13.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.79M | 19.32M | 17.41M | 2.42M | 13.16M |
| EBIT | 118.87M | 99.63M | 85.12M | 63.27M | 63.63M |
| EBITDA | 159.83M | 137.17M | 119.99M | 98.01M | 97.72M |
| EPS Basic | 0.78 | 0.48 | 0.43 | 0.06 | 0.33 |
| Normalized Basic EPS | 1.15 | 0.80 | 0.71 | 0.32 | 0.48 |
| EPS Diluted | 0.78 | 0.47 | 0.43 | 0.06 | 0.32 |
| Normalized Diluted EPS | 1.14 | 0.80 | 0.71 | 0.32 | 0.48 |
| Average Basic Shares Outstanding | 162.03M | 162.01M | 162.01M | 162.01M | 162.01M |
| Average Diluted Shares Outstanding | 162.61M | 162.42M | 162.21M | 162.13M | 162.03M |
| Dividend Per Share | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| Payout Ratio | 61.17% | 100.64% | 111.70% | 804.72% | 147.71% |